House Panel Provides NCI $1.7 Billion for 1991, Expects Greater Emphasis On Cancer Prevention
In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office
NCI Announces Designation Of Comprehensive Center
Columbus CCP Forms New Entity to Administer CCOP
Garfinkel to Retire From ACS; Health to Succeed Him
Fox Chase Biochemist Automates DNA Production
Broder Explains Where R01 Money Has Gone
AACR Honorary Memberships; ASCO Awards
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - As more people are surviving cancer, we must continue funding bold science









